Malignant mesothelioma has proven resistant to every cancer treatment. Physicians using varying combinations of chemotherapy, radiation, surgery, and immunotherapy have been able to extend survival for some patients, but have not yet found a way to stop the aggressive cancer from claiming the lives of its victims. Now researchers at the Roswell Park Cancer Center
When a person is diagnosed with malignant mesothelioma or any other asbestos-related cancer, they immediately focus on where their illness came from. Those who decide to pursue justice file suit against manufacturers and others who negligently exposed them to the carcinogen, and those companies generally take steps to defend themselves or to minimize their liability.
The statute of limitations in mesothelioma lawsuits and other similar personal injury cases is three years from when the victim knows or should have known of their illness. Though this may seem clear cut, asbestos companies often try to use this limitation to their advantage to have cases dismissed. A recent attempt to have a
Traditionally, exploring the roots of malignant mesothelioma involves examining how the body’s cells respond when exposed to asbestos. But a group of researchers from the University of Pennsylvania has taken a different approach, exploring how asbestos particles change once introduced into the body. This unique perspective may lead to new approaches to treatment.
As is true with so many other types of cancers, the first line of treatment for malignant mesothelioma is chemotherapy. Despite its many side effects, most mesothelioma patients receive chemotherapy as part of a multi-modality protocol that adds on surgery and/or radiation therapy. But as newer drugs are developed that approach cancer cells in different
Malignant mesothelioma is a notoriously difficult and deadly form of cancer. Providing patients with correct treatment from the outset is one of the keys to extending survival and quality of life. But distinguishing between the asbestos-related disease and other forms of cancer can be a challenge. A recent discovery by Italian scientists may solve that
Malignant mesothelioma is an insidious form of cancer that remains hidden in the body for decades. Seemingly healthy individuals are suddenly stricken with coughing, difficulty in breathing, chest pain and loss of appetite, and these symptoms are often mistaken for more common illnesses. This delays both diagnosis and appropriate treatment. Now researchers from Sweden are
Though the pandemic is not yet fully in the rear-view mirror, the availability of three different vaccines is making a big difference, especially for those at risk for malignant mesothelioma. The elderly men and women with a history of exposure to asbestos are among the first group to be eligible for immunizations, and once they
Early diagnosis is the key to longer survival and higher quality of life for patients diagnosed with malignant mesothelioma. But according to a recently conducted study published as a research letter in JAMA Network Open, there has been a decrease of almost 50% in new diagnoses of six types of cancer in the United States. Mesothelioma specialists
In response to the clear dangers that the coronavirus poses to patients diagnosed with mesothelioma and other thoracic malignancies, a group of international researchers has established a registry to determine whether cancer treatments pose an additional risk factor. The group recently released some of its earliest results, and reported that past treatment may in fact